# Magnevist Post-marketing Surveillance in Japan

> **NCT01376739** · — · COMPLETED · sponsor: **Bayer** · enrollment: 2051 (actual)

## Conditions studied

- Diagnostic Imaging

## Interventions

- **DRUG:** Gadopentetate dimeglumine (Magnevist, BAY86-4882)

## Key facts

- **NCT ID:** NCT01376739
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 2051 (ACTUAL)
- **Last updated:** 2011-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01376739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01376739, "Magnevist Post-marketing Surveillance in Japan". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT01376739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*